HoldingsChannel.com
Ironwood Pharmaceuticals insider buying image
The table below summarizes the most recent Ironwood Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Ironwood Pharmaceuticals insider buys are important for investors to follow.
DateInsiderPriceAmount
3-6-2024
Insider Buy
Jon R. Duane
$8.70
CAGR »
$60,204.00
6,920 shares
3-4-2024
Insider Buy
Sravan Kumar Emany
SVP, Chief Financial Officer
$9.38
CAGR »
$100,215.92
10,684 shares
9-15-2023
Insider Buy
Sravan Kumar Emany
SVP, Chief Financial Officer
$8.32
CAGR »
$300,119.04
36,072 shares
3-10-2021
Insider Buy
Alexander J. Denner
Director and >10% Owner
$10.38
CAGR »
$2,335,500.00
225,000 shares
3-5-2021
Insider Buy
Alexander J. Denner
Director and >10% Owner
$10.01
CAGR »
$7,758,750.00
775,000 shares
3-2-2021
Insider Buy
Alexander J. Denner
Director
$9.44
CAGR »
$12,737,960.00
1,350,000 shares
2-26-2021
Insider Buy
Edward P. Owens
Director
$8.90
CAGR »
$26,700.00
3,000 shares
2-25-2021
Insider Buy
Edward P. Owens
Director
$9.20
CAGR »
$110,370.00
12,000 shares
2-24-2016
Insider Buy
Edward P. Owens
Director
$8.32
CAGR »
$83,200.00
10,000 shares
11-5-2012
Insider Buy
Peter M. Hecht
Chief Executive Officer
$11.65
CAGR »
$582,500.00
50,000 shares

Also See: Institutional Holders of IRWD
Also See: SEC filings

IRWD Performance Since Insider Purchase
Below we present the annualized performance delivered by Ironwood Pharmaceuticals stock since 3-6-2024 (the date of the most recent insider purchase). The performance of the investment from the time Ironwood Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about IRWD being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2024
End date: 05/01/2024
Start price/share: $8.93
End price/share: $8.22
Dividends collected/share: $0.00
Total return: -7.95%
Annualized Gain: -53.74%
Starting investment: $10,000.00
Ending investment: $9,205.00
Years: 0.15

Ironwood Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Ironwood Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding IRWD

Quotes delayed 20 minutes

Email EnvelopeFree IRWD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the Ironwood Pharmaceuticals Insider Buying occurred are:

Caesars Entertainment Inc (New) Insider Buying
Evolv Technologies Holdings Insider Buying
89bio Insider Buying
Fluence Energy Insider Buying
Fulcrum Therapeutics Insider Buying
Fortinet Insider Buying
Health Catalyst Insider Buying
Standard BioTools Insider Buying
Pacific Biosciences of California Insider Buying
Palomar Holdings Insider Buying

Ironwood Pharmaceuticals Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.